OptimizeRx Announces Proposed Public Offering of Common Stock

Go back to OptimizeRx Announces Proposed Public Offering of Common Stock

Optimizerx Corporation (OPRX) Prices 2.1M Common Stock Offering by Shareholder at $10/Share

December 18, 2018 8:53 AM EST

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a shareholder of OptimizeRx, of 2,103,702 shares of OptimizeRx common stock, at a public offering price of $10.00 per share. In connection with the offering,... More